Certara's Q1 Adjusted EPS Misses Estimates at $0.09, Despite Revenue Beat
CERT sits 20% above its 52-week low of $5.19.
Summary
Certara reported Q1 adjusted EPS of $0.09, which missed the IBES estimate of $0.11. While the company's Q1 revenue of $106.9 million slightly exceeded the $106.1 million estimate, the miss on the bottom line is a significant concern for investors. This earnings report provides the first financial update since the full-year 2025 results, indicating a potential slowdown in profitability despite top-line growth. Professional traders would need to know about this immediately as an EPS miss often leads to negative stock price movement. Investors will be closely watching for management commentary on profitability trends and future guidance.
At the time of this announcement, CERT was trading at $6.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $967.5M. The 52-week trading range was $5.19 to $13.88. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.